Observed arrival · 2026-09-01
Global Peptide Index Counts the Evidence Behind 60 Compounds
A public index tracks registered clinical trials, FDA labels, jurisdictions, and research activity for 60 peptides.
○Open
⊠Login
$Paid
†Ads
✦Pretty
●Pro
◎Niche
◉Human
⚑Risk
ƒJS
Why it surfaced
Global Peptide Index puts the peptide boom against the evidence actually visible in public registers: seven compounds carry 500 or more trials, while several heavily searched names have only one to three. Its bluntest finding is also its most useful—15 of 60 compounds have no approved US product at all.
A public index tracks registered clinical trials, FDA labels, jurisdictions, and research activity for 60 peptides.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
○OpenPublic substance visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use
ƒJavaScriptBrowser-side code central
One card from the complete issue